1 / 5

Crohn's Disease Market Expected To Witness Sublimation With A CAGR Of 3%

According to a study conducted by Persistence Market Research (PMR), demand for anti-inflammatory drugs and biologics for treating Crohnu2019s disease will gain traction in the near future. PMR forecasts that the global market for Crohnu2019s disease is set to reach US$ 4,474.8 Million by 2024-end, growing at a CAGR of 3% during the assessment period.

persistencemarketresearch
Download Presentation

Crohn's Disease Market Expected To Witness Sublimation With A CAGR Of 3%

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Crohn's Disease Market Report Id : PMRREP9665 Category : Life Science & Healthcare ©2020 Persistence Market Research, All Rights Reserved

  2. About Persistence Market Research Customized Research Persistence Market Research(Persistence Market Research) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. Persistence Market Research is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for our client. Syndicated Research Investment Research Social Media Research Research Capabilities Sector Coverage • Automotive and Transportation • Electronics, Semiconductor, and ICT • Retail and Consumer Products • Industrial Automation and Equipment • Customized Research • Syndicated Research • Investment Research • Social Media Research • Chemicals & Materials • Food and Beverages • Services and Utilities • Energy, Mining, Oil, and Gas Subscription Information For detailed subscription information please contact Website: www.persistencemarketresearch.com For sales queries or new topics email us on: sales@persistencemarketresearch.com

  3. Crohn's Disease Market Expected To Witness Sublimation With A CAGR Of 3% Between 2024 The Crohn’s & Colitis Foundation of America (CCFA) stated that over 1 Million Americans were diagnosed with Crohn’s & ulcerative colitis disorders, with most of them aged above 30. Growing occurrence of Crohn’s disease has triggered a robust demand for its therapeutics. A survey conducted by the US Center for Disease Control (CDC) has revealed that the incidence rate of Crohn’s disease in the country is 3.1 to 14.6 new cases per 100,000 population annually. The disease is highly prevalent in developed countries, especially in individuals who smoke.  According to a study conducted by Persistence Market Research (PMR), demand for anti-inflammatory drugs and biologics for treating Crohn’s disease will gain traction in the near future. PMR forecasts that the global market for Crohn’s disease is set to reach US$ 4,474.8 Million by 2024-end, growing at a CAGR of 3% during the assessment period. Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/9665

  4. Market Overview While biologics will continue to remain the most preferred drug type amongst both healthcare professionals and patients, the demand for anti-inflammatory drugs will also witness a rampant acceleration during the forecast period. Based on drug type, the anti-inflammatory drug segment is projected to reach a market valuation of US$ 1,095.9 Million by end of the assessment period. Based on distribution channel, the hospital pharmacies will continue to be the leading segment of the market over the forecast period. Whereas, the retail pharmacies segment is projected to exhibit the highest growth, reaching a market valuation of US$ 1,470.2 Million by 2024. PMR’s findings based on regional assessment suggest that the Crohn’s disease market in North America will continue to lead the pack during the forecast period. The region’s market is expected to value US$ 3,149.8 Million over 2014. However, Asia-Pacific is expected to witness the highest CAGR over the forecast period. The APAC market is projected to create an absolute $ opportunity of US$ 13.2 Million in 2017 over 2016. Access Full Report @ https://www.persistencemarketresearch.com/checkout/9665

More Related